These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 154622)

  • 1. Serotonin agonist actions of p-chlorophenylalanine.
    Sloviter RS; Drust EG; Connor JD
    Neuropharmacology; 1978 Dec; 17(12):1029-33. PubMed ID: 154622
    [No Abstract]   [Full Text] [Related]  

  • 2. Paradoxical blockade by p-chlorophenylalanine of 5-hydroxytryptophan facilitatory actions on spinal reflexes.
    Taber CA; Anderson EG
    J Pharmacol Exp Ther; 1973 Nov; 187(2):229-38. PubMed ID: 4356011
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral and biochemical actions of p-chlorophenylethylamine (p-CPEA) in mice.
    Hwang EC; Van Woert MH
    Life Sci; 1979 Feb; 24(7):595-601. PubMed ID: 155767
    [No Abstract]   [Full Text] [Related]  

  • 4. Serotonergic properties of beta-phenethylamine in rats.
    Sloviter RS; Connor JD; Drust EG
    Neuropharmacology; 1980 Nov; 19(11):1071-4. PubMed ID: 6449675
    [No Abstract]   [Full Text] [Related]  

  • 5. A study of the tranylcypromine-meperidine interaction: effects of p-chlorophenylalanine and l-5-hydroxytryptophan.
    Gessner PK; Soble AG
    J Pharmacol Exp Ther; 1973 Aug; 186(2):276-87. PubMed ID: 4268957
    [No Abstract]   [Full Text] [Related]  

  • 6. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
    Sloviter RS; Drust EG; Damiano BP; Connor JD
    J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
    [No Abstract]   [Full Text] [Related]  

  • 8. Maternal aggression in mice: effects of treatments with PCPA, 5-HTP and 5-HT receptor antagonists.
    Ieni JR; Thurmond JB
    Eur J Pharmacol; 1985 May; 111(2):211-20. PubMed ID: 3160594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some 5-hydroxytryptamine-like actions of fenfluramine: a comparison with (+)-amphetamine and diethylpropion.
    Southgate PJ; Mayer SR; Boxall E; Wilson AB
    J Pharm Pharmacol; 1971 Aug; 23(8):600-5. PubMed ID: 4397744
    [No Abstract]   [Full Text] [Related]  

  • 10. Specificity of a rat behavioral model for serotonin receptor activation.
    Sloviter RS; Drust EG; Connor JD
    J Pharmacol Exp Ther; 1978 Aug; 206(2):339-47. PubMed ID: 682117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biogenic amines and head twitches in mice during ethanol withdrawal.
    Collier HO; Hammond MD; Schneider C
    Br J Pharmacol; 1974 Jun; 51(2):310-1. PubMed ID: 4281336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-selection of 5-hydroxytryptophan in dl-para-chlorophenylalanine treated rats.
    Nance DM; Kilbey MM
    Physiol Behav; 1972 Mar; 8(3):545-7. PubMed ID: 4260975
    [No Abstract]   [Full Text] [Related]  

  • 13. Para-halogenated phenethylamines: similar serotonergic effects in rats by different mechanisms.
    Sloviter RS; Connor JD; Damiano BP; Drust EG
    Pharmacol Biochem Behav; 1980 Aug; 13(2):283-6. PubMed ID: 6447879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-Chlorophenylalanine-induced alterations in the behavioral effects of 5-hydroxytryptophan.
    Boggan WO; Freedman DX
    Psychopharmacologia; 1973 Dec; 33(4):293-8. PubMed ID: 4272976
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurochemical and behavioural evidence for an agonist action of 1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine (LY 165163) at central 5-HT receptors.
    Hutson PH; Donohoe TP; Curzon G
    Eur J Pharmacol; 1987 Jun; 138(2):215-23. PubMed ID: 3113985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new animal model for schizophrenia: cholinergic and serotonergic modulation.
    Borison RL; Havdala HS; Diamond BI
    Commun Psychopharmacol; 1978; 2(3):209-14. PubMed ID: 308873
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential non-serotonergic basis of hyperphagia elicited by intraventricular p-chlorophenylalanine.
    Coscina DV; Daniel J; Warsh JJ
    Pharmacol Biochem Behav; 1978 Dec; 9(6):791-7. PubMed ID: 154674
    [No Abstract]   [Full Text] [Related]  

  • 18. An investigation on the behavioral and hypothermic effects of yohimbine: interaction with drugs affecting central and peripheral monoamines.
    Papeschi R
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):61-80. PubMed ID: 4276928
    [No Abstract]   [Full Text] [Related]  

  • 19. Yohimbine: behavioral and biochemical effects in mice.
    Sanghvi I; Gershon S
    Arch Int Pharmacodyn Ther; 1974 Jul; 210(1):108-20. PubMed ID: 4280277
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of p-chlorophenylalanine on opiate-induced running, analgesia, tolerance and physical dependence in mice.
    Cheney DL; Goldstein A
    J Pharmacol Exp Ther; 1971 Apr; 177(1):309-15. PubMed ID: 4254848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.